0000950170-23-071885.txt : 20231220 0000950170-23-071885.hdr.sgml : 20231220 20231220160854 ACCESSION NUMBER: 0000950170-23-071885 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kavuru Vimal CENTRAL INDEX KEY: 0001697184 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 231501425 MAIL ADDRESS: STREET 1: 11 MAACKA DRIVE CITY: HOLMDEL STATE: NJ ZIP: 07733 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-649-9272 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 ownership.xml 4 X0508 4 2023-12-19 0001444192 Acasti Pharma Inc. ACST 0001697184 Kavuru Vimal 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 true false true false false Stock Options (Right to Buy) 2.125 2023-12-19 4 A false 10000 0 A 2033-12-19 Class A Common Shares 10000 10000 D Stock options granted on 12/19/2023 under the Acasti Pharma Stock Option Plan, which vest in equal monthly installments over a period of 12 months, provided that 3/12 of the options shall be deemed to have vested upon the date of grant. /s/ Vimal Kavuru 2023-12-20